Trial intelligence / Profile preview

Bimatoprost in vitiligo

IRCT20250726066639N1Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Aug 2025
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of bimatoprost in Vitiligo, sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Aug 2025; status: completed.

02

Drugs

bimatoprost
03

Conditions

Vitiligo

Beyond the preview

Go deeper on IRCT20250726066639N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250726066639N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call